Tarina 24 Fe
Product Images NDC 53002-1789

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tarina 24 Fe (NDC 53002-1789). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl530021789)

The image shows the packaging label for TARINA 24 FE Tablets, a 1-month pack labeled by RPK Pharmaceuticals, Inc. The medication is a 24-day regimen with instructions to take 1 tablet daily as directed. The label includes space for clinic and prescriber information, lot number, expiration date, and billing NDC details.*

FDA Label Image

Figure-1 (Norethindroneethinyl Fig1)

A pharmacokinetic line graph showing Norethindrone concentration (pg/mL) over time (hours) comparing Day 1 and Day 24. The x-axis represents time up to 60 hours, and the y-axis shows Norethindrone concentration, peaking higher and declining more slowly on Day 24 (dotted line with circles) compared to Day 1 (solid line with dots).*

FDA Label Image

Figure-2 (Norethindroneethinyl Fig2)

A line graph showing Ethinyl Estradiol concentration (pg/mL) versus time (hours) for TARINA 24 FE. It compares Day 1 and Day 24 concentrations, with concentration peaking quickly after dosing and gradually declining over 60 hours. Day 24 values generally show higher concentrations than Day 1 throughout the time period.*

FDA Label Image

Figure (Norethindroneethinyl Fig3)

A chart illustrating the estimated pregnancies per 100 women in one year with different birth control methods, ranked from fewer to more pregnancies. It categorizes methods into groups: implants, injections, intrauterine devices, and sterilization showing fewer than 1 pregnancy; birth control pills, skin patch, and vaginal ring with hormones; condoms and diaphragm; followed by no sex during fertile days, spermicide, and withdrawal; ending with no birth control resulting in 85 or more pregnancies.*

FDA Label Image

Figure4 (Norethindroneethinyl Fig4)

Figure A is an instructional diagram showing a 28-day pill pack layout for TARINA 24 FE tablets by RPK Pharmaceuticals, Inc. The diagram includes rows labeled Week 1 through Week 4, with 7 daily pill positions per week arranged left to right. The first row has seven dark gray circles indicating active tablets, followed by three rows of empty circles for the remaining days. Arrows and text guide users to start taking pills from left to right each week, with instructions for Sunday or Day 1 starters.*

FDA Label Image

Structure-1 (Norethindroneethinyl Str1)

Chemical structure diagram of the active ingredient for TARINA 24 FE. The structure shows a steroid-like backbone with hydroxyl groups and a triple bond side chain, indicative of the compound's molecular design commonly found in hormonal medications.*

FDA Label Image

Structure-2 (Norethindroneethinyl Str2)

Chemical structure diagram showing the molecular formula of the active ingredient in TARINA 24 FE. The structure presents a steroid backbone with various functional groups including a ketone, methyl groups, and an acetyl group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.